Latest Articles

Subject

Research Article
Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD
Margherita Nosadini, Michael Eyre, Thea Giacomini, et al.

November 29, 2022
Research Article
Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors
Antonio Farina, Macarena Villagrán-García, Nicolás Lundahl Ciano-Petersen, et al.

November 29, 2022
Research Article
Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis
Eleni S. Vasileiou, Chen Hu, Charles N. Bernstein, et al.

November 23, 2022
Review
Secondary Progressive Multiple SclerosisA Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying Therapies
Tjalf Ziemssen, Virender Bhan, Jeremy Chataway, et al.

November 22, 2022
Research Article
More Efficient Complement Activation by Anti–Aquaporin-4 Compared With Anti–Myelin Oligodendrocyte Glycoprotein Antibodies
Magdalena Lerch, Kathrin Schanda, Eliott Lafon, et al.

November 22, 2022
Research Article
Serum Neurofilament Identifies Patients With Multiple Sclerosis With Severe Focal Axonal Damage in a 6-Year Longitudinal Cohort
Falk Steffen, Timo Uphaus, Nina Ripfel, et al.

November 21, 2022
Research Article
Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination
Anna G. Francis, Kariem Elhadd, Valentina Camera, et al.

November 21, 2022
Research Article
Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine TabletsA MAGNIFY-MS Substudy
Heinz Wiendl, Klaus Schmierer, Suzanne Hodgkinson, et al.

November 21, 2022
Research Article
Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
Nicolás Fissolo, Agustin Pappolla, Jordi Rio, et al.

November 21, 2022
Research Article
Sustained Low Relapse Rate With Highly Variable B-Cell Repopulation Dynamics With Extended Rituximab Dosing Intervals in Multiple Sclerosis
Chiara Starvaggi Cucuzza, Elisa Longinetti, Nicolas Ruffin, et al.

November 21, 2022

Pages